Experience:
No experience
Employment Type:
Intern/Co-op
Posted:
2/20/2019
Job Category:
Accounting
Summer Intern - Finance, Accounts Payable
(This job is no longer available)
Seattle Genetics | Bothell, WA
loading
loading
School
Major
Grad Date
 
 

Not sure what types of jobs you are interested in?


Explore Jobs
Based on Your Education

Follow This Company
Share

Job Description

Help the AP team with miscellaneous tasks such as invoice entry, disbursements, coding of invoices. Help with specific projects that come up during the year.

Responsibilities:

* Invoice entry
* Disbursements
* Filing
* Coding
* Help others on AP Team

Qualifications:

* Understanding of General Accounting practices
* Good internal/external communication
* Microsoft Excel, Word etc.
* Prior knowledge of a robust ERP system (not required)
* ----------------------------------------

Note: This is a paid internship. This position is open to all students legally authorized to work in the United States. We are not able to offer visa sponsorships. While housing is not provided by SeaGen we make every effort to connect fellow interns to arrange for joint housing and ride sharing.

As the leading employer in our industry in the Pacific Northwest, Seattle Genetics is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. Benefits include medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Seattle Genetics, please visit www.seattlegenetics.com.

Seattle Genetics is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law.

About Seattle Genetics

Seattle Genetics, Inc. is a clinical-stage biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The Company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize the product candidate SGN-40. It also has two other product candidates in clinical trials, SGN-33 and SGN-35, and several lead preclinical product candidates including SGN-70, SGN-75 and an anti-CD19 antibody-drug conjugate (ADC). In addition to its internal pipeline, the Company has ADC license agreements with a number of biotechnology and pharmaceutical companies including Genentech, Bayer Pharmaceuticals Corporation, CuraGen Corporation, Progenics Pharmaceuticals, Inc. and MedImmune Inc., a wholly owned subsidiary of AstraZeneca PLC, as well as an ADC co-development agreement with Agensys Inc., a wholly owned subsidiary of Astellas Pharma. (Source: 10-K)